类风湿关节炎患者中CD4+CD8αlow T细胞克隆扩增依赖于共刺激信号
研究采用单细胞RNA及T细胞受体测序分析3例类风湿关节炎(RA)患者和2例健康对照的CD4+CD8+ T细胞克隆性,并用流式细胞术检测53例RA、52例银屑病关节炎(PsA)和50例健康供者的外周CD4+CD8+ T细胞及其亚群。RA患者CD4+CD8αlow T细胞增多且属于大克隆,阿巴西普治疗12周后其频率显著下降并与疾病活动度降低相关。
要点
- RA患者外周CD4+CD8αlow T细胞较PsA患者和健康对照增多。
- CD4+CD8αlow T细胞属于大T细胞克隆,在scRNA-seq中与CD4+CD8- T细胞克隆分开聚类。
- 阿巴西普治疗12周显著降低RA患者外周CD4+CD8αlow T细胞频率,并与疾病活动度降低相关。
核心结论
- RA患者中CD4+ T细胞克隆扩增最终导致外周CD4+CD8αlow T细胞出现,这些细胞与疾病活动度相关,并在阿巴西普治疗后减少,可能参与疾病发病机制。
研究设计与样本
- 单细胞RNA测序和单细胞T细胞受体测序分析RA患者(n=3)和健康对照(n=2)的CD4+CD8+ T细胞。
- 流式细胞术检测RA患者(n=53)、PsA患者(n=52)和健康供者(n=50)的外周CD4+CD8+ T细胞及其亚群。
- 前瞻性观察RA患者接受阿巴西普治疗12周期间CD4+CD8+ T细胞频率的变化。
主要发现
- 与PsA患者和健康对照相比,RA患者表达CD8α的CD4+ T细胞增多。
- 克隆性分析显示这些CD4+CD8αlow T细胞属于大T细胞克隆,在scRNA-seq基因表达分析中与CD4+CD8- T细胞克隆分开聚类。
- 阿巴西普治疗显著降低外周CD4+CD8αlow T细胞频率,且这与疾病活动度降低相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: CD4+CD8+ T cells are increased in patients with rheumatoid arthritis (RA). They are not only associated with joint erosions in established disease but are also present in the preclinical stages of RA. This study aims to further investigate their expansion in the context of T cell clonality in patients with RA, as well as their responsiveness to T cell-targeted treatment. METHODS: Single-cell RNA (scRNA) and single-cell T cell receptor (TCR) sequencing data were used to determine coreceptor expression and TCR sequences to assess the clonality of CD4+CD8+ T cells in patients with RA (n = 3) and healthy controls (n = 2). Peripheral CD4+CD8+ T cells and their subpopulations were measured in patients with RA (n = 53), patients with psoriatic arthritis (PsA; n = 52), and healthy donors (n = 50) using flow cytometry. In addition, changes in CD4+CD8+ T cell frequency were prospectively observed in patients with RA receiving therapy with abatacept for 12 weeks. RESULTS: We observed an increase of CD4+ T cells expressing CD8α in patients with RA, both in comparison to patients with PsA and healthy controls. Clonality analysis revealed that these CD4+CD8αlow T cells are part of large T cell clones, which cluster separately from CD4+CD8- T cell clones in the scRNA sequencing (scRNA-seq) gene expression analysis. Treatment with abatacept significantly reduced the frequency of peripheral CD4+CD8αlow T cells, and this was linked to reduction in disease activity. CONCLUSION: In patients with RA, clonal expansion of CD4+ T cell culminates in the emergence of peripheral CD4+CD8αlow T cells, which are associated with disease activity and diminished upon abatacept treatment and could contribute to disease pathogenesis.
引用
- Beck F, Nguyen P, Hoffmann A, et al. CD4+CD8αlow T Cell Clonal Expansion Dependent on Costimulation in Patients With Rheumatoid Arthritis. Arthritis Rheumatol. 2024. PMID: 39054665. doi:10.1002/art.42960
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。